Social media marketing for biotech companies: Which platforms work and why
Not every social media platform deserves your attention. For a biotech company with a B2B focus, a small marketing team, and a specialist audience, the question is not “should we be on social media”, it is “where will our time and budget actually produce results.”
The honest answer is that two or three platforms done well will consistently outperform six platforms done inconsistently. The challenge is knowing which two or three those are for your specific audience, commercial model, and content capabilities.
This blog walks through each major platform, what it delivers for biotech companies, what it does not, and how to prioritise your investment based on what you are trying to achieve.
Table of contents
- Why platform choice matters more in life sciences than in most sectors
- Platform 1: LinkedIn - The primary channel for B2B life sciences
- Platform 2: X/Twitter - Useful but not the priority for most
- Platform 3: YouTube - High value, high effort
- Platform 4: Instagram - Relevant in specific circumstances
- Platform 5: Facebook - Declining relevance for B2B life sciences
- A practical prioritisation framework
- What actually drives results, regardless of platform
- Conclusion
Why platform choice matters more in life sciences than in most sectors
Life sciences audiences are niche by nature. Your prospects, whether researchers, procurement managers, clinical scientists, pharma executives, or biotech investors, are not evenly distributed across social platforms. They concentrate in specific places, engage with specific types of content, and have limited tolerance for poorly targeted or scientifically inaccurate material.
This concentration means that platform selection is not just a tactical decision, it directly affects whether your content reaches the right people at all. A life science company producing excellent content on the wrong platform is producing content that nobody who matters will see.
The second factor is resource reality. Most life science companies, particularly at the startup and scale-up stage, do not have the team to maintain a high-quality presence on five platforms simultaneously. Attempting to do so invariably produces mediocre content everywhere rather than strong content somewhere.
Platform 1: LinkedIn - The primary channel for B2B life sciences
For the vast majority of B2B life science companies, LinkedIn is where the most relevant professional audience spends time and where the clearest return on social media investment exists.
80% of B2B leads generated through social media originate on LinkedIn. 94% of B2B marketers use LinkedIn to distribute content.1 These figures show that LinkedIn is built for professional identity, which means your content reaches people in their professional context rather than their leisure time.
What performs on LinkedIn for biotech companies
- Posts with photos or videos consistently outperform text-only posts for the healthcare and life sciences sector on LinkedIn.2
- Thought leadership from individual profiles, the CEO, lead scientists, business development leads, outperforms the same content from the company page. People connect with people.
- Commenting strategically on content from relevant industry voices, potential partners, sector journalists, investors, is one of the most underused tactics for B2B life sciences brands. When you regularly engage in the right conversations, your brand becomes visible to the right audiences without requiring viral content or a large existing following.3
LinkedIn’s median engagement rate across all industries is approximately 3,3%. This means LinkedIn consistently generates more interaction per post than X (Twitter), Facebook, and TikTok for B2B content.2
Posting frequency
Hootsuite’s healthcare sector research found that companies posting twice per week or twenty times per week see the highest average engagement, with companies posting sporadically in between seeing the worst results.2 The takeaway is not that you should post twenty times per week, but that consistency at whatever frequency you choose matters more than raw volume.
For life sciences companies, two to three posts per week is a realistic and effective cadence.
For a detailed breakdown of LinkedIn strategy, ad formats, targeting, and measurement, see our LinkedIn marketing guide for life science companies.
Platform 2: X/Twitter - Useful but not the priority for most
X has an active life sciences and biotech community. Scientists, researchers, clinicians, and biotech journalists are disproportionately present on the platform relative to other sectors. Hashtags like #scicomm, #biotech, and #clinicaltrial have active followings. This makes X genuinely more relevant for life sciences than for many B2B categories.
When X makes sense for biotech companies:
- If your target audience includes academic researchers or scientists who are active on the platform
- For real-time engagement around conferences, clinical milestones, or sector news
- If your company communicates on topics, genomics, AI in drug discovery, regulatory developments, where active conversations are happening on X
When X is not worth the investment:
- If your primary audience is pharma procurement managers, hospital administrators, or corporate business development professionals, they are more concentrated on LinkedIn
- If your team does not have the capacity to monitor the platform and engage in real time, X works primarily as a conversation medium, not a broadcast one
Our recommendation: maintain an active presence on X only if your specific audience segment is genuinely there and your team has the capacity to engage responsively. For most life science companies with limited resource, LinkedIn delivers better returns on the same time investment.
Platform 3: YouTube - High value, high effort
YouTube is the world’s second-largest search engine after Google.4 YouTube Shorts generate more than 50 billion daily views globally, and have the highest engagement rate of any short-form video format at 5.91%.5,6
For life science companies with genuinely complex science to communicate, YouTube has a specific and valuable role: long-form explainer videos, product demonstrations, laboratory walkthroughs, and expert interviews that cannot be adequately expressed in a LinkedIn post or a 60-second clip.
Several large life science companies use YouTube effectively. They maintain channels that blend scientific education content with corporate storytelling, positioning them as credible sector voices while reaching audiences well beyond their existing stakeholder networks.
The challenge for smaller biotech companies
YouTube demands significantly more production resources than any other platform. A well-produced 3-5 minute explainer video requires scripting, filming, editing, and distribution, a significant time investment for most early-stage companies.
YouTube Shorts lowers that barrier considerably. If your company can produce short video content, a scientist explaining a key concept in under a minute, a product demo in 90 seconds, a conference takeaway, YouTube Shorts combined with LinkedIn video is a realistic combination for companies with limited production capacity.
Our recommendation: YouTube is worth investing in once LinkedIn is running consistently, and you have a content production process in place. For pre-Series A companies, it is typically better to defer YouTube in favour of channels with lower production overhead.
Platform 4: Instagram - Relevant in specific circumstances
Instagram has a 3.7% average engagement rate across industries in 2026.6 For most B2B biotech companies targeting pharma procurement or clinical professionals, Instagram is a lower priority than LinkedIn or YouTube.
That said, there are three scenarios where Instagram is genuinely worth developing:
Employer branding and talent attraction. Instagram is where potential hires, particularly younger scientists and researchers entering the workforce, form impressions of a company’s culture. Behind-the-scenes lab content, team profiles, and mission-driven storytelling perform well here and directly support recruitment goals.
Patient and public-facing communications. If your company’s work touches patient communities, clinical trial recruitment, disease education, and patient support, Instagram reaches that audience in a way LinkedIn does not.
Scientific communication to a broader public. Some biotech companies use Instagram to build a non-specialist following around their science, translating complex research into accessible visual content. This is particularly effective for companies working in areas with strong public interest, such as oncology, rare diseases, or neuroscience.
Content format note: Hootsuite’s healthcare sector benchmark data shows that Instagram carousel posts earn more engagement than Reels or static photos for healthcare, pharma, and biotech organisations.2 If you invest in Instagram, prioritise carousels for educational content.
Platform 5: Facebook - Declining relevance for B2B life sciences
For B2B life science companies, Facebook is the lowest priority of the platforms covered here.
Facebook’s organic reach for business pages has been under 2% for several years, meaning the vast majority of people who follow your page will not see your posts without paid amplification.6 Life science professionals are also meaningfully less concentrated on Facebook in a professional context than on LinkedIn.
Facebook does retain value in one specific scenario: paid advertising to consumer audiences, patient communities, healthcare consumers, or job seekers, where Meta Ads allow precise demographic targeting at lower CPCs than LinkedIn. For B2B targeting of professional decision-makers, LinkedIn advertising remains more precise.
Our recommendation: unless you have a specific B2C objective or a large existing Facebook community to maintain, Facebook is not where limited life science marketing resources should be directed.
A practical prioritisation framework
Objective | Primary platform | Secondary |
B2B lead generation | — | |
Investor and partner visibility | X/Twitter | |
Talent attraction and employer brand | ||
Science communication and education | YouTube | |
Conference engagement | X/Twitter | |
Patient and public-facing communications |
The clearest version of this for most biotech companies:
If you are a B2B biotech startup or scale-up with one primary commercial audience and limited marketing resources, the correct answer is almost always: LinkedIn first, consistently, for at least six months before considering any other platform. Add a second platform only when LinkedIn is running at a sustainable pace and you have evidence that your target audience is active elsewhere.
What actually drives results, regardless of platform
Platform choice matters, but it is secondary to these principles, which apply across all channels:
Consistency beats volume. An account that posts reliably twice a week will outperform one that posts ten times in a burst and then goes quiet. Platform algorithms reward regular activity.7
Engaging in conversations outperforms broadcasting. For B2B life sciences specifically, commenting thoughtfully on posts from relevant industry voices generates visibility with exactly the right audience. This is particularly true as LinkedIn’s algorithm now distributes content based on topic relevance and engagement patterns.3
Individual voices outperform company pages. Content from named individuals with a recognisable perspective generates more engagement and trust than the same content from a corporate handle, across all platforms. Invest in helping your founders and scientists build their own presence, it benefits the company more than most expect.8
Measure the metrics that matter. Follower count and impressions are easy to track but tell you little about business impact. Focus instead on what is actually measurable:
- Website traffic from LinkedIn: trackable in Google Analytics 4 by filtering on linkedin.com as traffic source. This tells you how many people clicked through to your site from LinkedIn content or your company page.
- Follower demographics: LinkedIn Page Analytics shows a breakdown of your followers and page visitors by job function, seniority, and industry. Check quarterly whether your target audience types are actually following you, or whether your following is drifting toward less relevant profiles.
- Lead Gen Form completion rate: if you run paid LinkedIn campaigns with Lead Gen Forms, LinkedIn reports completions directly.
Conclusion
There is no universal social media strategy for biotech companies. What works depends on your audience, your commercial model, your content capabilities, and your stage of growth.
What is consistent across nearly every B2B life science company: LinkedIn is where the most relevant professional audience concentrates, and consistent, substantive presence there, through both company page activity and individual thought leadership, delivers the clearest return on social media investment.
Start there. Build consistency. Add platforms only when you have evidence that your target audience is active on them and when you have the capacity to show up consistently.
Questions or need guidance? Send us a message, we’re happy to help!
Any questions about life sciences marketing?
Let's talk!
Frequently asked questions about social media for biotech companies
Which social media platform is most important for biotech companies?
For B2B biotech companies, LinkedIn is the most important platform. It generates 80% of B2B social media leads, and it’s where the professional audiences that matter most (researchers, pharma executives, investors, procurement managers) are most concentrated.
Should biotech companies be on X/Twitter?
It depends on your specific audience. X has an active scientific and biotech community, making it relevant for companies targeting academic researchers, clinicians, or journalists. For companies primarily targeting corporate business development or procurement professionals, LinkedIn delivers better returns on the same time investment.
Is YouTube worth it for a small biotech startup?
YouTube is high-value but high-effort. It makes the most sense once LinkedIn is running consistently and you have a production process in place. YouTube Shorts lowers the production barrier significantly and has the highest engagement rate of any short-form video format. For pre-Series A companies, deferring YouTube in favour of lower-overhead channels is a reasonable prioritisation.
How often should biotech companies post on social media?
Consistency matters more than frequency. For LinkedIn, two to three times per week is a sustainable and effective cadence. For healthcare, pharma, and biotech organisations on Instagram, posting at least twice per week maintains engagement. Concentrating on one or two platforms at a consistent cadence produces better results than spreading effort across many at low frequency.
How do we measure whether social media is actually working?
Focus on metrics tied to business outcomes rather than vanity metrics. For LinkedIn: website clicks attributed to LinkedIn (trackable in Google Analytics 4), engagement from target job titles (visible in LinkedIn analytics), and direct inbound enquiries where the prospect mentions LinkedIn. For paid campaigns: cost per lead compared to your acceptable cost per lead based on average deal value.
When should a biotech company work with a specialist agency for social media?
When internal bandwidth limits consistency, when paid campaign management requires expertise your team does not have, or when you need a content strategy tied to commercial objectives rather than ad-hoc posting. A specialist life science marketing agency with sector expertise can significantly reduce the time required to build a coherent social presence. See our social media management service for how we approach this.
References
- https://www.businessdasher.com/research/b2b-social-media-statistics/
- https://blog.hootsuite.com/healthcare-social-media-benchmarks/
- https://www.knbcomm.com/blog/b2b-health-biotech-social-media-in-2026-comments-are-king
- https://open.library.okstate.edu/introtosocialmedia/chapter/youtube-the-worlds-second-largest-search-engine/
- https://open.library.okstate.edu/introtosocialmedia/chapter/youtube-the-worlds-second-largest-search-engine/
- https://posteverywhere.ai/blog/social-media-engagement-rate-benchmarks
- https://buffer.com/resources/consistent-posting-study
- https://meet-lea.com/en/blog/linkedin-personal-profile-vs-company-page-engagement
